tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dianthus price target raised to $62 from $60 at Oppenheimer
PremiumThe FlyDianthus price target raised to $62 from $60 at Oppenheimer
2M ago
Dianthus Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Dianthus Therapeutics Reports Q3 2025 Financial Results
2M ago
Dianthus Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
Premium
Ratings
Dianthus Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
2M ago
Dianthus Therapeutics Advances Phase 2 Study of DNTH103 for Neuropathy
PremiumCompany AnnouncementsDianthus Therapeutics Advances Phase 2 Study of DNTH103 for Neuropathy
3M ago
Dianthus Therapeutics: Strategic Positioning and Innovative Pipeline Justify Buy Rating
Premium
Ratings
Dianthus Therapeutics: Strategic Positioning and Innovative Pipeline Justify Buy Rating
3M ago
Dianthus Therapeutics’ Strategic Moves and Pipeline Potential Justify Buy Rating
Premium
Ratings
Dianthus Therapeutics’ Strategic Moves and Pipeline Potential Justify Buy Rating
3M ago
Short Report: Dave & Busters bears boost exposure
PremiumThe FlyShort Report: Dave & Busters bears boost exposure
4M ago
3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
4M ago
Dianthus initiated with a Buy at Clear Street
Premium
The Fly
Dianthus initiated with a Buy at Clear Street
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100